Covetrus, Inc.

DB:2NJ 株式レポート

時価総額:€3.0b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Covetrus 過去の業績

過去 基準チェック /06

主要情報

-7.8%

収益成長率

-9.8%

EPS成長率

Healthcare 業界の成長15.7%
収益成長率7.1%
株主資本利益率-0.9%
ネット・マージン-0.3%
前回の決算情報30 Jun 2022

最近の業績更新

Recent updates

収支内訳

Covetrus の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

DB:2NJ 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 224,649-137230
31 Mar 224,621-407280
31 Dec 214,575-547140
30 Sep 214,575-567090
30 Jun 214,539-907140
31 Mar 214,376-136850
31 Dec 204,339-266980
30 Sep 204,225-197000
30 Jun 204,117-9406300
31 Mar 204,100-9966880
31 Dec 193,976-9806610
30 Sep 193,871-9485760
30 Jun 193,776275870
31 Mar 193,772655040
29 Dec 183,7781014850
30 Sep 183,791695470
30 Jun 183,776745430
31 Mar 183,649675320
30 Dec 173,580644600
31 Dec 163,353704890
26 Dec 152,978604180

質の高い収益: 2NJ is currently unprofitable.

利益率の向上: 2NJ is currently unprofitable.


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 2NJ is unprofitable, and losses have increased over the past 5 years at a rate of 7.8% per year.

成長の加速: Unable to compare 2NJ's earnings growth over the past year to its 5-year average as it is currently unprofitable

収益対業界: 2NJ is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (1.4%).


株主資本利益率

高いROE: 2NJ has a negative Return on Equity (-0.85%), as it is currently unprofitable.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘